Alessandro Chiesi

Cornerstone Therapeutics, Inc. operates as a pharmaceutical company. The firm engages in the development and commercialization of products for the hospital, rare disease and adjacent specialty care settings. It acquires, develops and commercializes prescription pharmaceutical drugs. The company was founded on October 31, 2008 and is headquartered in Cary, NC.

Asche Chiesi GmbH provides research, development and sale of medicinal products. It offers solutions for therapeutic areas such as respiratory, cardiovascular, musculoskeletal, inflammation and neonatology. The company produces respiratory dosage forms such as metered-dose inhalers and sterile unit dose vials for nebulisation. It offers solutions for the treatment of asthma and chronic obstructive pulmonary diseases. The company was founded in 2002 and is headquartered in Hamburg, Germany.

DOC Generici Srl manufactures and distributes generic drugs. The firm offers medicines for the treatment of chronic diseases such as cardiovascular and neurological. The company was founded in 1996 and is headquartered in Milan, Italy.

Chiesi Farmaceutici SpA develops and markets pharmaceutical products. The firm specializes in research, development and production of drugs in respiratory dosage forms, such as metered-dose inhalers and sterile unit dose vials. The company was founded by Giacomo Chiesi in 1935 and is headquartered in Parma, Italy.

Chiesi Ltd. develops and markets respiratory products. It offers medicines for the treatment of respiratory disease. The company was founded on June 18, 1987 and is headquartered in Manchester, the United Kingdom.

Borealis Tech Ventures Srl (Management) (Borealis Tech Ventures), is an independent venture capital investment firm. The firm was founded by Vittorio Bertazzoni, Giampaolo Cagnin, Alessandro Chiesi, Francesco Mutti, Pietro Negra, Andrea Casalini in 2014. The firm is headquartered in Parma, Italy.

Matras Interplastic SpA is an Italian company that manufactures and distributes thermoplastic polymers and resins. The private company was founded in 1960. The CEO is Alessandro Chiesi.

Part of Valline Srl, Chiesi SA (Belgium) is a Belgian pharmaceutical company specializing in the treatment of respiratory diseases, neonatology, rare diseases, and special care. Chiesi SA (Belgium is based in Machelen, BE. The company's focus on innovation and patient care has led to collaborations with other organizations, such as Affibody, and the development of new treatments for rare diseases. Chiesi SA (Belgium is committed to sustainability and participates in events such as Climbing for Life. The company was founded in 2010 by Giacomo Chiesi, and the CEO is Alberto Chiesi.